Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Ovarian Neoplasms

Free Subscription Articles published in Hum Pathol Retrieve available abstracts of 21 articles: HTML format

Single Articles

November 2023
1. QIJUN C, Wei W, Cheng W, Dongni L, et al
   Clinicopathological features and molecular genetic changes in 17 cases of uterine tumor resembling ovarian sex cord tumor.
   Hum Pathol. 2023 Nov 22:S0046-8177(23)00229.
   PubMed     Abstract available
   
   
   September 2023
2. KOLB S, Hoffmann I, Monje N, Dragomir MP, et al
   LRP1B - a prognostic marker in tubo-ovarian high-grade serous carcinoma.
   Hum Pathol. 2023 Sep 22:S0046-8177(23)00186.
   PubMed     Abstract available
   
   
   
3. D'ANGELO E, Espinosa I, Felicioni L, Buttitta F, et al
   Ovarian High-grade Serous Carcinoma with Transitional-like (SET) Morphology: A Homologous Recombination-deficient Tumor.
   Hum Pathol. 2023 Sep 4:S0046-8177(23)00185-5. doi: 10.1016/j.humpath.2023.
   PubMed     Abstract available
   
   
   March 2023
4. SIEGMUND SE, Mehra R, Acosta AM
   An update on diagnostic tissue-based biomarkers in testicular tumors.
   Hum Pathol. 2023;133:32-55.
   PubMed     Abstract available
   
   
   January 2023
5. LU B, Xia Y, Chen J, Tang J, et al
   NCOA1/2/3 rearrangements in uterine tumor resembling ovarian sex cord tumor: a clinicopathological and molecular study of 18 cases.
   Hum Pathol. 2023 Jan 13:S0046-8177(23)00012.
   PubMed     Abstract available
   
   
   October 2022
6. ZAFAR R, Schrader LJ, Cheville JC, Schoolmeester JK, et al
   A diagnostic approach to paratesticular lesions with tubulopapillary architecture: a series of 16 serous borderline tumors/low-grade serous carcinoma and 14 well-differentiated papillary mesothelial tumors and mesothelioma.
   Hum Pathol. 2022;128:31-47.
   PubMed     Abstract available
   
   
   June 2022
7. LONDERO AP, Orsaria M, Viola L, Marzinotto S, et al
   Survivin, Sonic hedgehog, Kruppel-like factors, and p53 pathway in serous ovarian cancer: an immunohistochemical study.
   Hum Pathol. 2022 Jun 28. pii: S0046-8177(22)00168.
   PubMed     Abstract available
   
   
   May 2022
8. MCCLUGGAGE WG, Stewart CJR, Belcijan NL, Mourad S, et al
   Neuroectodermal elements are part of the morphological spectrum of DICER1-associated neoplasms.
   Hum Pathol. 2022;123:46-58.
   PubMed     Abstract available
   
   
   April 2022
9. SILVA EG, Lawson BC, Ramalingam P, Liu J, et al
   Precursors in the Ovarian Stroma, Another Pathway to Explain the Origin of Ovarian Serous Neoplasms.
   Hum Pathol. 2022 Apr 12. pii: S0046-8177(22)00087.
   PubMed     Abstract available
   
   
   March 2022
10. ZHANG L, Zhang L, Wang XI, Katz G, et al
    The value of SOX2 in the differential diagnosis of SMARCA4 (BRG1)-deficient uterine neoplasms.
    Hum Pathol. 2022 Mar 21. pii: S0046-8177(22)00070.
    PubMed     Abstract available
    
    
    August 2021
11. VISSER NCM, van der Wurff AAM, IntHout J, Reijnen C, et al
    Improving preoperative diagnosis in endometrial cancer using systematic morphological assessment and a small immunohistochemical panel.
    Hum Pathol. 2021 Aug 18. pii: S0046-8177(21)00148.
    PubMed     Abstract available
    
    
    
12. SHETTY S, Habeeb O, Rivera C, Astbury C, et al
    MDM2 amplification in malignant Brenner tumors may play a role in progression to malignancy and aid in separation from urothelial and other ovarian carcinomas.
    Hum Pathol. 2021 Aug 12. pii: S0046-8177(21)00141.
    PubMed     Abstract available
    
    
    July 2021
13. SIATECKA H, Masand RP
    Brenner tumor associated with rete ovarii: a histologic and immunohistochemical analysis of six cases exploring the relationship between these entities.
    Hum Pathol. 2021;113:84-91.
    PubMed     Abstract available
    
    
    June 2021
14. LAWSON BC, Yang RK, Euscher ED, Ramalingam P, et al
    TP53 Variant Allele Frequency Correlates with the Chemotherapy Response Score in Ovarian/Fallopian Tube/Peritoneal High-Grade Serous Carcinoma.
    Hum Pathol. 2021 Jun 18. pii: S0046-8177(21)00110.
    PubMed     Abstract available
    
    
    April 2021
15. ZHANG Y, Jeyachandran D, Desouki MM
    Grossly Unremarkable Cervix in Endometrial Carcinomas: LVSI and MELF Pattern may be Associated with High Incidence of Cervical Stromal Involvement.
    Hum Pathol. 2021 Apr 29. pii: S0046-8177(21)00069.
    PubMed     Abstract available
    
    
    
16. NIU N, Shen W, Zhong Y, Bast RC Jr, et al
    Expression of B7-H4 and IDO1 is associated with drug resistance and poor prognosis in high-grade serous ovarian carcinomas.
    Hum Pathol. 2021 Apr 19. pii: S0046-8177(21)00054.
    PubMed     Abstract available
    
    
    December 2020
17. HALIMI SA, Maeda D, Ushiku-Shinozaki A, Goto A, et al
    Comprehensive immunohistochemical analysis of the gastrointestinal and Mullerian phenotypes of 139 ovarian mucinous cystadenomas.
    Hum Pathol. 2020 Dec 1. pii: S0046-8177(20)30239.
    PubMed     Abstract available
    
    
    November 2020
18. SILVA E, Malpica A, Roma A, Ramalingam P, et al
    Ovarian Mucinous Neoplasms, Intestinal Type, in Premenopausal Patients, Develop in Abnormal Ovaries.
    Hum Pathol. 2020 Nov 20. pii: S0046-8177(20)30231.
    PubMed     Abstract available
    
    
    June 2020
19. ROTH LM, Cheng L
    Gonadoblastoma: origin and outcome.
    Hum Pathol. 2020;100:47-53.
    PubMed     Abstract available
    
    
    April 2020
20. TESSIER-CLOUTIER B, Cochrane DR, Karnezis AN, Colborne S, et al
    Proteomic Analysis of Transitional Cell Carcinoma-Like Variant of Tubo-Ovarian High-Grade Serous Carcinoma.
    Hum Pathol. 2020 Apr 29. pii: S0046-8177(20)30047.
    PubMed     Abstract available
    
    
    February 2020
21. WIEDEMEYER K, Kobel M, Koelkebeck H, Xiao Z, et al
    High GLYPICAN-3 expression Characterizes a Biologically Distinct subset of ovarian clear cell carcinomas in Canadian patients: An Opportunity for targeted Therapy.
    Hum Pathol. 2020 Feb 1. pii: S0046-8177(20)30015.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge.